INTRODUCTION
Cyclooxygenase (COX) isozymes 1 and 2 are the ratelimiting steps in the biosynthesis of prostaglandins (PGs). Both of the enzymes convert arachidonic acid to PGH 2 . PGH 2 is then converted to various PGs by specific synthases. COX-2 is induced by a variety of stimulants, whereas COX-1 represents its noninducible counterpart. COX-2 is expressed in both of the epithelial [1] and stromal cells of the human endometrium. Human endometrial glandular epithelium contains the highest levels of COX, although whether it is COX-1, COX-2, or both has not been determined [2] . COX-2 plays an obligatory role in blastocyst implantation and in the decidualization of endometrial stromal cells, whereas fertilization proceeds normally without COX-1 [3] .
PGs such as PGE 2 and PGF 2␣ are locally produced in 1 endometrium. Numerous PGE 2 binding sites are widely present in endometrium. PGF 2␣ binding sites, although present in endometrium, are few in number [4] . PGs, mainly PGE 2 , are necessary for increased vascular permeability at the site of implantation and for increased local blood flow [5] . A COX inhibitor, indomethacin, can block implantation in rodents, and this blockade can be overcome by administration of PGs [6] . PGs also initiate endometrial plasminogen activator expression in the rat and thus may be involved in tissue remodeling associated with trophoblast invasion [7] . Transcripts coding PG receptors have been found in mouse luminal endometrial epithelium, the expression of which is coincident with the time of expected implantation [8] .
A recent study showed the involvement of PGF 2␣ in the expression of COX-2 in ovine luteal cells, indicating positive feedback stimulation in PG synthesis [9] . PGs bind with specific receptors and stimulate the intracellular signal transduction system. It is likely that other PGs, including PGE 2 , may also cause a similar effect, provided that specific receptors and the signaling molecules are present. For the effects of PGF 2␣ , Ca 2ϩ -and protein kinase C (PKC)-mediated signaling pathways were believed to be responsible. But depending on the agonist, other protein kinases were found to be involved in the expression of COX-2, including mitogen-activated protein (MAP) kinase [10, 11] and a recently reported phosphatidylinositol-3-OH kinase, PI3K [12] .
MAP kinase or extracellular signal-regulated kinase (ERK) is widely distributed in eukaryocytes as a family of serine/threonine protein kinases. MAP kinase was originally reported to be activated by growth factors and to be involved in proliferation and differentiation of cells through stimulation of gene expression. Subsequently, it was found that agents that bind with G protein-coupled receptors can also increase the activation of MAP kinase. In previous work, we reported that COX-2 expression increased, probably through the MAP kinase pathway, in response to stimulation of hCG receptors in HEC-1B cells [12] . Similarly, in GH3 cells, the secretion of prolactin was stimulated by treatment with thyrotropin releasing hormone (TRH) in correlation with activation of MAP kinase [13] . Furthermore, activation of MAP kinase protected apoptosis of GH3 cells induced with bromocriptine [14] .
PGE 2 binds with a type of G protein-coupled receptor, and most of the cellular effects mediated by PGE 2 were explained by its ability to increase cAMP, and thereby activate protein kinase A (PKA) [15, 16] . cAMP has a variable effect on MAP kinase activity, either increasing [17] or decreasing [18] the activity, depending on cell types.
The HEC-1B cell line originated from endometrial adenocarcinoma and is a substrain of HEC-1A. HEC-1B cells are morphologically epithelial-like, and retain many of the characteristics of endometrial epithelial cells. HEC cells are reported to have both estradiol [19] and progesterone receptors [20] and can express COX-2 upon stimulation. Thus, because the HEC-1B cell line has many properties that are common to normal endometrial epithelial cells, this cell line is a valuable model for the study of regulation of COX-2. Our aim was to examine the effect of PGE 2 in the expression of COX-2 and the signaling pathways involved, using HEC-1B cells.
MATERIALS AND METHODS
The following chemicals and reagents were obtained from the indicated sources: fetal bovine serum (FBS), JRH Biosciences (Lenexa, KS); [␥- 32 [21] .
Cell Culture
HEC-1B cell line was obtained from ATCC, Bethesda, MD. Cells were cultured in MEM supplemented with 10% FBS, 1 mM sodium pyruvate, and 60 mg/L kanamycin. Cell cultures were maintained in a humidified atmosphere of 5% CO 2 and 95% air at 37ЊC. The medium was replaced every 3-4 days and the cells were split every 4-5 days using trypsin (0.05% v/v) in Mg 2ϩ -free and Ca 2ϩ -free PBS. Cells were plated in 35-mm dishes for MAP kinase assay and in 100-mm dishes for immunoblot analysis and were cultured for 3-5 days in the same medium, including 10 nM estradiol and 1 M medroxyprogesterone acetate to reach around 60% confluency.
Immunoblot Analyses of COX-2 and COX-1
In our previous experiments, we found that the expression of COX-2 significantly increased by treatment with PAF and hCG in HEC-1B cells cultured in the presence of both of 10 nM estradiol and 1 M medroxyprogesterone acetate [12] . A similar result was also obtained when the cells were treated with PGE 2 (data not shown). Therefore, we used cells pretreated with 10 nM estradiol and 1 M medroxyprogesterone acetate for all of the following experiments.
HEC-1B cells were incubated for 12 h in the absence or presence of 1 M PGE 2 after the cells were cultured for 3-5 days in presence of estradiol and medroxyprogesterone acetate. After incubation, the medium was quickly aspirated off and the cells were frozen in liquid N 2 and kept at Ϫ80ЊC until assayed.
The frozen cells were scraped off the dishes and solubilized in 0.30 ml of 50 mM HEPES (pH 7.4), 0.1% Triton X-100, 4 mM EGTA, 10 mM EDTA, 15 mM Na 4 P 2 O 7 , 100 mM ␤-glycerophosphate, 25 mM NaF, 0.1 mM leupeptin, 75 M pepstatin A, 1 mM dithiothreitol, and 1 mM (pamidinophenyl)-methanesulfonyl fluoride hydrochloride (solubilization solution). The procedures for treatment of cells were carried out at 0-4ЊC. After sonication (Sonifier 250; Branson, Danbury, CT), the insoluble material was removed by centrifugation at 15 000 ϫ g for 5 min. The extracts were treated with SDS sample buffer [22] and boiled for 3 min. Fifty g of these protein samples were then subjected to SDS-PAGE in 10% acrylamide and then electrophoretically transferred at 75 V for 2 h to a nitrocellulose membrane. After incubating the membrane in 4.5% skimmed milk-Tris buffered saline (TBS; 10 mM Tris-buffered isotonic saline, pH 7.4) for 2 h to block nonspecific binding sites, the membrane was incubated overnight at 4ЊC with the monoclonal COX-2 antibody at a 1: 125 dilution. After washing, the membrane was incubated with the anti-mouse IgG 1 at a 1:200 dilution for 2 h and finally with [ 125 I] protein A at room temperature for 1 h. After the membrane was dried, the amount of radioactivity was quantified by a Bio-imaging analyzer (BA100; Fujifilm, Tokyo, Japan).
For COX-1 immunoblotting, the procedure was essentially similar as described for COX-2, with the exception that COX-1 antibody (1:200 dilution) was used instead of COX-2 antibody and anti-mouse IgG 1 was omitted from the procedure.
Assay for MAP Kinase
Cells cultured in the presence of 10 nM estradiol and 1 M medroxyprogesterone acetate were washed once with Krebs-Ringer HEPES buffer (KRH buffer) containing 128 mM NaCl, 5 mM KCl, 1 mM sodium phosphate, 1.2 mM MgSO 4 , 10 mM glucose, 2.7 mM CaCl 2 , and 20 mM HE-PES (pH 7.4), and were preincubated at 37ЊC for 1 h in the same buffer. Then the cells were incubated at 37ЊC for the specified times with none (control) or specified test agents in KRH buffer. After incubation for the indicated times, the medium was quickly aspirated off, and the cells were frozen in liquid N 2 and kept at Ϫ80ЊC until the assay was performed.
The frozen cells were scraped off the dishes and solubilized in 0.15 ml solubilization solution having the same composition as described earlier for COX-2 assay, with the exception that 1 mM Na 3 VO 4 and 100 nM calyculin A were also included. Cells were sonicated and centrifuged as described earlier. Samples containing the same amount of protein (10-15 g of protein) were subjected to elecrophoresis in 10% polyacrylamide gel containing myelin basic protein (MBP). The procedures following this step is essentially similar to those described by Kurino et al. [23] . Briefly, after electrophoresis, the gel was washed, denatured, and renatured by appropriate buffers. The gel was then preincubated for 1 h with 40 mM HEPES, 2 mM DTT, 10 mM MgCl 2 , and 0.1 mM Na-orthovanadate at 30ЊC. Incubation of the gel was performed for 30 min in a buffer described for preincubation, in which 25 Ci [␥ 32 P]ATP, 25 mM cold ATP, and 25 mM EGTA were also added. The gel was washed and dried, and the amount of 32 P incorporation into MBP at the position of MAP kinase in the gel was quantified with a Bio-imaging analyzer (BA 100; Fujifilm).
For immunoblot analysis of MAP kinase, cells were cultured in 100-mm dishes and incubated at 37ЊC with none (control) or PGE 2 in KRH buffer for the indicated times as described in the figure legends. The rest of the procedure was similar to that described earlier for COX-2, with the exception that the antibody against the 42-kDa isoform of MAP kinase (also called ERK-2) was used (1:500 dilution) and the anti-mouse IgG 1 antibody was omitted.
Immunohistochemical Analysis of MAP Kinase
Cells cultured in 35-mm dishes in the presence of 10 nM estradiol and 1 M medroxyprogesterone acetate were washed once with KRH buffer and preincubated at 37ЊC for 1 h in the same buffer. Then the cells were incubated at 37ЊC for 10 min with nothing (control) or PGE 2 in KRH buffer. After incubation the medium was quickly aspirated off, kept over dry ice, and enough volume of methanol was added to cover the cell surface in the dish. After 10 min, methanol was aspirated off and the dish was dried, and kept at Ϫ30ЊC until immunohistochemistry was performed.
The frozen cells were washed with PBS and permeabilized with PBS ϩ 0.01% Triton X-100. After incubating the cells in 0.3% BSA in PBS ϩ 0.01% Triton X-100 for 30 min to block nonspecific binding sites, the cells were incubated overnight at 4ЊC with phospho-MAP kinase antibody (1:50 dilution) and nonphospho-MAP kinase antibody (1:50 dilution). After washing, the cells were incubated again with fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG (1:40 dilution) for 1 h. The cells were then stained with propidium iodide for 2 min before mounting, and then examined under a confocal laser scanning light microscope (CLSM; Olympus, Japan).
Immunoblot Analysis of Protein Kinase B
Cells cultured in 100-mm dishes in the presence of 10 nM estradiol and 1 M medroxyprogesterone acetate were washed once with KRH buffer and preincubated at 37ЊC for 1 h in the same buffer. Then the cells were incubated at 37ЊC for 3 min with nothing (control) or specified test agents in KRH buffer. After incubation for the indicated times, the medium was quickly aspirated off, and the cells were frozen in liquid N 2 and kept at Ϫ80ЊC until the assay was performed.
The frozen cells were scraped from the dishes, solubilized in 0.2 ml RIPA solution (50 mM Tris-HCl pH 7.4], 0.15 M NaCl, 0.5% Triton X-100, 10 mM EDTA, 1 mM Na 3 VO 4 , 30 mM Na 4 P 2 O 7 , 50 mM NaF, and 4 mM EGTA) containing 0.1 mM leupeptin, 75 M pepstatin A, 1 mM dithiothreitol, 1 mM (p-amidinophenyl)-methanesulfonyl fluoride hydrochloride, and 100 nM calyculin A. The rest of the procedures were essentially the same as was performed for COX-2 immunoblot with some modifications. One hundred g of the protein samples were subjected to SDS-PAGE in 10% acrylamide and then transferred to a nitrocellulose membrane. The membrane was incubated overnight at 4ЊC with phospho-PKB (1:200 dilution) or nondiscriminating PKB antibody (1:1000 dilution). For phospho-PKB, the membrane was incubated again in [ 125 I] protein A for 1 h. For total PKB, after incubation with the nondiscriminating PKB antibody, the membrane was washed in TBS ϩ NP40 and incubated for 1 h with horseradish peroxidase-conjugated anti-sheep IgG. The bands were then visualized using an ECL detection kit.
Other Procedures
Protein concentrations were determined according to the method of Bradford [24] with bovine serum albumin as the standard.
Statistical Analyses
Each experiment was performed in triplicate and repeated at least two to three times. Results were consistent experiment to experiment. Values are expressed as mean Ϯ SEM. Statistical significance of data was analyzed by using either two-way ANOVA or one-way ANOVA followed by Duncan's test for multiple comparisons. P Ͻ 0.05 was considered significant.
RESULTS

Expression of COX-2 by PGE 2
We examined the expression of COX-2 at 0 h, 4 h, 8 h, 12 h, 16 h, and 24 h following stimulation of the cells with 1 M PGE 2 (Fig. 1, A and C) . The expression of COX-2 protein significantly increased by 180% of control 8 h after PGE 2 stimulation and continuously increased with increasing times. On the other hand, COX-1, the noninducible isoform of COX protein, did not change after PGE 2 stimulation (Fig. 1B) . The cells that were not treated with PGE 2 showed no change in COX-2 expression during the period examined (Fig. 1C) .
HEC-1B cells were treated for 12 h with PGE 2 at concentrations ranging from 0.01 M to 10 M to determine whether the effect of PGE 2 on COX-2 expression was dosedependent (Fig. 1D) . Maximum COX-2 expression was obtained with 100 nM PGE 2 . There was no significant difference in the expression of COX-2 between 100 nM and 1 M concentrations when analyzed statistically. A higher concentration of PGE 2 (10 M) inhibited COX-2 expression.
Time Course of PGE 2 -Stimulated MAP Kinase Activation MAP kinase is also called extracellular signal-regulated kinase (ERK) and includes a 44-kDa ERK-1 and a 42-kDa ERK-2. HEC-1B cells contain the 42-kDa isoform of MAP kinase [12] . The time course of PGE 2 -induced MAP kinase activation is shown in Figure 2 , A and C. The cells were incubated with 1 M PGE 2 for up to 30 min. MAP kinase activation was measured from 5 to 30 min after stimulation with PGE 2 . The maximal activation of MAP kinase was obtained 10 min after stimulation with PGE 2 and then decreased gradually. A significant level of MAP kinase activity was still observed even at 30 min. The cells that were not treated with PGE 2 showed no change in MAP kinase activation during the period examined (Fig. 1C ). The MAP kinase protein level was same along the time course as shown by immunoblot analysis (Fig. 2B) .
Immunohistochemical Analysis of MAP Kinase Activation by PGE 2
MAP kinase is a cytosolic enzyme that is translocated in the nucleus upon activation. To supplement the observation of MAP kinase activation by in-gel kinase assay, the cells were immunostained with the phospho-MAP kinase antibody by comparing the staining of the nuclei with propidium iodide (Fig. 3) . MAP kinase, a cytosolic protein during its inactivated form, translocates to the nucleus of the cell upon activation. In the event of nuclear translocation of activated MAP kinase, double staining of the nucleus of the cell will occur at the images recorded simultaneously through the FITC and propidium iodide channel. Although the cytoplasms of HEC-1B cells were immunostained with the phospho-MAP kinase antibody (Fig. 3A) , Values are expressed as a percentage of control (without PGE 2 at zero time), which is taken as 100%. Values are mean Ϯ SEM (bars; n ϭ 3). *P Ͻ 0.05, **P Ͻ 0.01 versus control (without PGE 2 at zero time). We analyzed the response for two treatments of nonstimulation (dotted line) and stimulation (solid line) without and with PGE 2 , respectively, over time by two-way ANOVA, which was significant (P Ͻ 0.0001).
the immunoreactivity strongly increased following PGE 2 stimulation (Fig. 3E) . It is also noteworthy that the nuclei of HEC-1B cells were double-stained with the phospho-MAP kinase antibody and propidium iodide, indicating that activated MAP kinase is localized in the nuclei (Fig. 3G) . On the other hand, when MAP kinase antibody was used, which cannot discriminate the phosphorylated and nonphosphorylated forms, there was no difference in immunoreactivity after PGE 2 stimulation (Fig. 3, D and H) . Thus, it is apparent that the activation of MAP kinase was increased after stimulation with PGE 2 .
Effects of Protein Kinase Inhibitors on PGE 2 -Mediated MAP Kinase Activation
To determine the activation pathway of MAP kinase by stimulation with PGE 2 , effects of PD098059, H-89, calphostin C, and wortmannin were examined (Fig. 4) . The concentrations of these inhibitors used for our experiments were based on previous reports [25] [26] [27] [28] . PD098059, a specific inhibitor of MEK [25] , could completely inhibit activation of MAP kinase stimulated by PGE 2 at 75 M concentration (Fig. 4, A and C) . Activation of MAP kinase was also entirely inhibited by the addition of 10 M H-89 (Fig. 4, A and C) , which selectively inhibits PKA [26] . On the other hand, calphostin C, a selective inhibitor of PKC [27] , failed to inhibit MAP kinase activation by PGE 2 (Fig.  4, A and C) . When used alone, none of the inhibitors showed any effect on MAP kinase activation compared with controls (data not shown). The inhibitors did not affect viability of HEC-1B cells (data not shown). There was no change in MAP kinase protein levels in different treatment conditions (Fig. 4B) . Collectively, our data indicate that the inhibitors affected the activity of MAP kinase and that the activation of MAP kinase by PGE 2 is dependent on a cAMP pathway rather than PKC.
We also wanted to know whether PI3K is involved in this MAP kinase activation pathway. Wortmannin is a spe- cific inhibitor of PI3K at nanomolar concentrations [28] . Although wortmannin was found to be involved in some G protein-coupled receptor-mediated MAP kinase activation [29] , in our study, it had no effect on PGE 2 -induced activation of MAP kinase (Fig. 4, A and C) .
Activation of PKB by PGE 2
PKB is a serine/threonine kinase lying downstream of PI3K. Activation of PKB is indirect evidence of PI3K stimulation. To investigate whether PGE 2 can activate PKB, we measured phosphorylated PKB levels by immunoblot analysis. As shown in Figure 5 , A and C, phosphorylated PKB levels increased significantly at 3 min after stimulation with PGE 2 , as recognized by phospho-PKB antibody directed against Ser-473 residue. Wortmannin, a specific inhibitor for PI3K, completely inhibited the effect. However, when the anti-PKB antibody was used, which cannot discriminate phosphorylated and nonphosphorylated forms, there was no change in protein level following PGE 2 stimulation (Fig.  5B) . This result indicates the activation of PKB by PGE 2 in HEC-1B cells. It also suggests that this activation is dependent on PI3K, because wortmannin completely abolished the effect.
Effects of Protein Kinase Inhibitors on PGE 2 -Induced Expression of COX-2
To examine functional consequences of protein kinases on PGE 2 -induced expression of COX-2, we used specific pharmacologic inhibitors of signal transduction pathways (Fig. 6 ). Approximately 50% of COX-2 stimulated by PGE 2 was inhibited by PD098059, suggesting involvement of MAP kinase (Fig. 6, A and C) . H-89 also partially inhibited COX-2 expression (Fig. 6, A and C) . Because H-89 could also inhibit MAP kinase activation stimulated by PGE 2 , it was likely that inhibition of MAP kinase by H-89 is related to the inhibition of COX-2 expression. Calphostin C failed to inhibit PGE 2 -induced COX-2 expression (Fig.  6, A and C) , suggesting that PKC is not involved in the expression of COX-2 by PGE 2 . When inhibitors were used alone, none showed any effect on COX-2 expression compared with controls (Fig. 6A) .
In a view to understand any contribution of PI3K pathway to COX-2 expression, we treated the cells with wortmannin and examined the ability of PGE 2 in COX-2 expression. It is interesting that wortmannin could inhibit approximately 40% of COX-2 induced by PGE 2 (Fig. 6 , A and C), suggesting a role for PI3K. In addition, when wortmannin and PD098059 were used together, a total inhibition of COX-2 expression was observed (Fig. 6, A and C) . As expected, none of the inhibitors had any effect on COX-1 protein levels (Fig. 6B) . Our data show collectively that both MAP kinase and PI3K pathways are involved in the expression of COX-2 by PGE 2 .
DISCUSSION
In the present study, we have demonstrated that PGE 2 can stimulate the expression of COX-2 in HEC-1B cells. If PGE 2 stimulates COX-2 expression in vivo, the present finding will suggest that in addition to its role in implantation and decidualization, PGE 2 can regulate endometrial functions by inducing COX-2 protein. Tsai et al. [9] demonstrated the ability of PGF 2␣ in the expression of COX-2 in ovine luteal cells. Our results and results published by Tsai et al. provide evidence of the presence of a positive feedback loop in the production of PGs.
Given that both human endometrial and HEC-1B cells express COX-2, in addition to a range of similarity between these two cells [19, 20, 30] , the use of HEC-1B cells in the present study is appropriate and relevant to human endometrial epithelial cell COX-2 physiology. In the present study, we demonstrated that PGE 2 in 10 nM to 1 M concentrations, which are well within the physiological levels, was effective in expressing COX-2 in HEC-1B cells. Similarly, we observed the activation of MAP kinase and PKB with 1 M PGE 2 . These protein kinases were found to be involved in the expression of COX-2 in our study. PGE 2 is released from both proliferative and secretory endometrial cells in culture [31] . Both of the epithelial and stromal cells of human endometrium contain numerous PGE 2 and very few or no detectable PGF 2␣ binding sites [4] . Therefore, the present findings suggest that locally produced PGE 2 may increase the expression of COX-2 in endome- trial epithelial cells by involving MAP kinase and PKB pathways.
Cellular effects of PGE 2 are known to be mediated by a subfamily of G protein-coupled receptors, designated EP receptors. Four distinct EP receptor subtypes (EP1, EP2, EP3, and EP4) have been cloned and expressed [32] . EP1 and EP3 receptors are coupled to Ca 2ϩ mobilization and inhibition of adenylate cyclase, respectively, whereas EP2 and EP4 receptors are both coupled to stimulation of adenylate cyclase [32] . In rat luminal epithelium, EP2 receptor mRNA expression occurs around the time of implantation [8] . Most of the cellular effects mediated by PGE 2 were explained by its ability to increase cAMP, and thereby, activation of PKA [15, 16] . There is only one report of the activation of MAP kinase with PGE 2 in COS7 cells transfected with EP3 receptors [33] . In the present study, 1 M PGE 2 could activate MAP kinase in HEC-1B cells in a time-dependent manner. By using the specific inhibitors of the protein kinases we demonstrated that MAP kinase activity was dependent on MEK and PKA. This indicates the ability of cAMP in the MAP kinase activation process. CPT-cAMP, a potent analogue of cAMP, also activates MAP kinase in HEC-1B cells [12] . In neurons, which express B-Raf rather than Raf-1, cAMP-activated MAP kinase was dependent on the activation of Rap1, a small GTPbinding protein [17] . We did not examine the activation of B-Raf by PGE 2 in HEC-1B cells, but the ineffectiveness of calphostin C and the effectiveness of H-89 in PGE 2 -induced activation of MAP kinase indicates a role for cAMP in the MAP kinase activation process, which may be mediated by EP2 or EP4 subtypes of PGE 2 receptor. Given the presence of EP2 receptor in endometrial epithelial cells, this study indicates the potential for MAP kinase activation after binding with PGE 2 . In addition to MAP kinase, we provided evidence, for the first time, of the activation of PKB by PGE 2 . PKB, which is also known as Akt, is a serine/threonine kinase. PKB activation is a widespread phenomenon occurring through intrinsic tyrosine kinase receptors for growth factor-and insulin-associated tyrosine kinase receptors for IL-5 and IL-4 receptors, and G protein-coupled serpentine receptors for PAF. PKB is a downstream target for PI3K and has been shown to bind to and be activated by PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 signaling molecules generated by PI3K after lipid phosphorylation [34] . In the present study, wortmannin, a specific inhibitor of PI3K in nanomolar concentrations, could completely inhibit the activation of PKB by PGE 2 . This suggests the involvement of PI3K in PKB activation in HEC-1B cells. The activated PKB influences the metabolism through phosphorylation of glycogen synathase kinase-3 and phosphofructokinase, as well as transmission of a potent antiapoptotic signal [35] . The antiapoptotic signal may be mediated in part by phosphorylation and inactivation of Bad, a proapoptotic BCL-2 family member [35] . In endometrium there is expression of BCL-2 during the proliferative phase in endometrial glandular cells [36] . Expression of BCL-2 in endometrial stromal cells has also been described. There is a rise in stromal BCL-2 expression from the proliferative to the menstrual phase [37] . The in vivo regulation of the expression of this gene is not hormonally driven [36] and it is possible that PGE 2 , which is present in endometrium regardless of hormonal status, can take part in this process. In nonendometrial cells, PGE 2 was found to inhibit apoptosis, in which PKA has been implicated [38] .
In our study, MAP kinase was found to be partially responsible for the expression of COX-2. A MAP kinase inhibitor, PD098059, partially inhibited PGE 2 -mediated COX-2 expression in this study. This is consistent with previous reports in which PD098059 was found to block the stimulation of lysophosphatidic acid-mediated COX-2 expression in rat mesangial cells [39] and lipopolysaccharideinduced COX-2 expression in a murine macrophage cell line [40] . We also found that CPT-cAMP directly stimulates COX-2 expression in HEC-1B cells [12] and that PGE 2 -induced COX-2 expression is partially inhibited by H-89. Because H-89 also inhibited PGE 2 -induced MAP kinase activation, it appeared that MAP kinase is the ultimate effector in this kinase cascade.
Although recent studies have paid considerable attention to the role of MAP kinase in the expression of COX-2, evidence is lacking to show the role of the PI3K pathway in the expression of COX-2. Previously, we demonstrated the existence of a wortmannin-sensitive pathway in PAFmediated COX-2 expression in the HEC-1B cell line [12] . In the present study, we extended our observation and found that wortmannin could partially inhibit the PGE 2 -induced expression of COX-2. The ability of PGE 2 to activate PKB, which is inhibited by wortmannin, provides evidence of a novel PI3K-PKB cascade, which may play a role in the expression of COX-2. The function of PKB still remains elusive. It was previously shown that the rapamycin-sensitive p70 s6 kinase can be activated by an oncogenic form of PKB, whereas PI3K inhibitors have been shown to inhibit p70 s6 kinase activation [41, 42] . p70 s6 Kinase participates in the translational control of mRNA transcripts encoding ribosomal proteins for the protein synthetic machinery. It is interesting that wortmannin was also found to inhibit protein synthesis by affecting translation [43] . This raises a possibility of the involvement of the PI3K-PKB pathway in the translation of COX-2. On the other hand, PKB was translocated into the nucleus [44] and could activate CREB following activation [45] . The COX-2 promoter region has the binding site for CREB and raises the possibility of a transcriptional control.
The present findings may also be important for understanding endometrial hyperplasias and carcinomas. It is a question whether PGE 2 receptor is overexpressed in these conditions, which may lead to the continuous stimulation of COX-2 synthesis. COX-2 was found to be overexpressed in some form of cancers [46] . The high PG levels produced from constant COX-2 stimulation can increase cell proliferation, decrease apoptosis, and decrease adhesion to extracellular matrix proteins [46, 47] . PGE 2 -mediated activation of PKB can be an alternate mechanism for the decrease of apoptosis.
In summary, treatment of the human uterine epithelial cell line, HEC-1B, with PGE 2 results in a time-and dosedependent increase in COX-2 expression. PGE 2 also activates MAP kinase and PI3K pathways, and they were found responsible for mediating the PGE 2 signal for the expression of COX-2. Further experiments are required to confirm the significance of these findings in a physiological situation in endometrium.
